¿Cómo se comparó el EPS reciente de 06955.HK con las expectativas?
¿Cómo fue el desempeño de los ingresos de Shandong Boan Biotechnology Co., Ltd. 06955.HK en el último trimestre?
¿Cuál es la estimación de ingresos para Shandong Boan Biotechnology Co., Ltd.?
¿Cuál es la puntuación de calidad de ganancias de Shandong Boan Biotechnology Co., Ltd.?
¿Cuándo informa Shandong Boan Biotechnology Co., Ltd. sus ganancias?
¿Cuáles son las ganancias esperadas de Shandong Boan Biotechnology Co., Ltd.?
¿Superó Shandong Boan Biotechnology Co., Ltd. las expectativas de ganancias?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
4.4M
EPS (TTM)
0.07
Dividend yield
--
Piyasa Değeri
--
BOAN BIOTECH nedir?
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. The company is headquartered in Yantai, Shandong and currently employs 714 full-time employees. The company went IPO on 2022-12-30. The firm is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The firm has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The firm operates mainly in the domestic Chinese market and overseas markets.